Researchmoz added Most up-to-date research on "Motion Sickness Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" to its huge collection of research reports.
Motion sickness is a common disorder that occurs due to the vestibular disturbances and conflicts created between vestibules, visual, and proprioceptive systems of the body. Pathogenesis of motion sickness is not understood completely. Motion sickness can be of different types depending on the cause. It can be seasickness, airsickness, or boat sickness depending on the motions exposed such as sea travel, air travel, or boat travel. There are different symptoms involved as a result of motion sickness such as nausea, vomiting, dizziness, headache, and irritability. Nausea is the most common among all the symptoms. Initial symptoms of this disorder can include yawning, belching, hypersalivation, heartburn, and frequent urination. Approximately, 70% to 80% population suffers from motion sickness during travel. Intensity of the sickness changes from person to person.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1586266
Motion sickness is self-diagnosable and treatable with several OTC and prescription drugs. Moreover, there are many natural ways to treat it. Early diagnosis and preventive treatment is more beneficial in this syndrome. Children and adults both can be affected by this disorder. Both medicated and non-medicated treatments are effective against it. Frequent travel for business, rapid growth in tourism, increase in availability of vehicles to commute, advancements in travel facilities, and increase in awareness are the factors driving the global motion sickness treatment market. However, adverse effects associated with the use of medications restrain the market.
The global motion sickness treatment market can be broadly classified based on route of administration, type of medication, distribution channel, and region. In terms of route of administration, the global market can be classified into oral, transdermal, and parenteral. The oral route is the most commonly used and accounts for the largest market share. However, scopolamine is the first choice of drug in treating motion sickness and is most effective via transdermal route. Based on type of medication, the market can be segmented into OTC drugs and prescription drugs. These segments can be further sub-segmented into anticholinergics, antihistamines (first-generation) and others. Anticholinergic drug scopolamine is witnessing significant growth owing to rise in awareness among consumers. Antihistamines are also a choice of medicines and account for the largest share owing to easy availability and effective orally. Based on distribution channel, the global motion sickness treatment market can be divided into online pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies account for the largest share of the global motion sickness market due to easy availability of these medications as OTC drugs.
Browse Detail Report @ https://www.researchmoz.us/motion-sickness-treatment-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html
Geographically, the worldwide transdermal scopolamine market can be segmented into Latin America, North America, Middle East & Africa, Europe, and Asia Pacific. Well-established health care industry, high health care expenditure, and surge in usage of transdermal scopolamine in surgeries and post-operative recovery are attributed to North America’s dominance of the global market. Asia Pacific is projected to present significant opportunities in the market owing to increase in health care expenditure, rise in awareness about prevention and treatment of motion sickness, and surge in focus of key industry players to expand in the region.
Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., CVS Health, and Myungmoon Pharma Co. Ltd. are the leading players operating in the global transdermal scopolamine market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1586266
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Motion sickness is a common disorder that occurs due to the vestibular disturbances and conflicts created between vestibules, visual, and proprioceptive systems of the body. Pathogenesis of motion sickness is not understood completely. Motion sickness can be of different types depending on the cause. It can be seasickness, airsickness, or boat sickness depending on the motions exposed such as sea travel, air travel, or boat travel. There are different symptoms involved as a result of motion sickness such as nausea, vomiting, dizziness, headache, and irritability. Nausea is the most common among all the symptoms. Initial symptoms of this disorder can include yawning, belching, hypersalivation, heartburn, and frequent urination. Approximately, 70% to 80% population suffers from motion sickness during travel. Intensity of the sickness changes from person to person.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1586266
Motion sickness is self-diagnosable and treatable with several OTC and prescription drugs. Moreover, there are many natural ways to treat it. Early diagnosis and preventive treatment is more beneficial in this syndrome. Children and adults both can be affected by this disorder. Both medicated and non-medicated treatments are effective against it. Frequent travel for business, rapid growth in tourism, increase in availability of vehicles to commute, advancements in travel facilities, and increase in awareness are the factors driving the global motion sickness treatment market. However, adverse effects associated with the use of medications restrain the market.
The global motion sickness treatment market can be broadly classified based on route of administration, type of medication, distribution channel, and region. In terms of route of administration, the global market can be classified into oral, transdermal, and parenteral. The oral route is the most commonly used and accounts for the largest market share. However, scopolamine is the first choice of drug in treating motion sickness and is most effective via transdermal route. Based on type of medication, the market can be segmented into OTC drugs and prescription drugs. These segments can be further sub-segmented into anticholinergics, antihistamines (first-generation) and others. Anticholinergic drug scopolamine is witnessing significant growth owing to rise in awareness among consumers. Antihistamines are also a choice of medicines and account for the largest share owing to easy availability and effective orally. Based on distribution channel, the global motion sickness treatment market can be divided into online pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies account for the largest share of the global motion sickness market due to easy availability of these medications as OTC drugs.
Browse Detail Report @ https://www.researchmoz.us/motion-sickness-treatment-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html
Geographically, the worldwide transdermal scopolamine market can be segmented into Latin America, North America, Middle East & Africa, Europe, and Asia Pacific. Well-established health care industry, high health care expenditure, and surge in usage of transdermal scopolamine in surgeries and post-operative recovery are attributed to North America’s dominance of the global market. Asia Pacific is projected to present significant opportunities in the market owing to increase in health care expenditure, rise in awareness about prevention and treatment of motion sickness, and surge in focus of key industry players to expand in the region.
Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., CVS Health, and Myungmoon Pharma Co. Ltd. are the leading players operating in the global transdermal scopolamine market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1586266
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
No comments:
Post a Comment